| Pharmaceutical active ingredients: |
| ClioquinolMesulfenPrednisoloneSalicylic Acid |
| Available forms, composition and doses of Polyderm: |
| N / A |
| Polyderm medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D10AB05 - MesulfenP01AA52 - Clioquinol, combinationsP03AA03 - Mesulfen |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Chowgule |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Polycrol Forte Tablets | Aluminum Hydroxide-Magnesium Carbonate-Co Dried Gel; Magnesium Hydroxide; Simethicone | Roche; Nicholas Piramal; Reckitt Benckiser; Zurich, South Africa |
| Polycrol Gel | Aluminum Hydroxide; Magnesium Hydroxide; Simethicone | Roche; Nicholas Piramal; Zurich, South Africa |
| Polycrol Tablets | Aluminum Hydroxide-Magnesium Carbonate-Co Dried Gel; Magnesium Hydroxide; Simethicone | Roche; Nicholas Piramal; Zurich, South Africa |
| Polycutan | Clotrimazole; Dexamethasone Acetate; Neomycin Sulfate | Perrigo |
| Polycycline | Tetracycline | Unidentified Pharmaceutical Company |
| Polyderm | Bacitracin Zinc; Polymyxin B Sulfate | Taro Pharmaceutical Industries |
| Polyderm Antibiotic | Bacitracin; Lidocaine Hydrochloride; Polymyxin B Sulfate | Pharmetics |
| Polydesis | Polyvinyl Alcohol | Unidentified Pharmaceutical Company |
| Polydex | Dextromethorphan Hydrobromide | Pharmasant Laboratories; Central Poly Trading |
| Poly-Dex | Dexamethasone; Neomycin Sulfate; Polymyxin B Sulfate | CYNACON / OCuSOFT |